drugset / Trial / NCT06700109

INJECTABLE COLD ENERGY THERAPY FOR THE MANAGEMENT OF CHRONIC PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE

NCT06700109

Active not recruiting 263 enrolled Brixton Biosciences, Inc.
RandomizedParallel-groupSingle-blindTreatment

Summary

The goal of this clinical trial is to evaluate the effectiveness of Neural Ice for pain management associated with knee osteoarthritis in adults aged 22-80 years. Participants will attend study visits and complete subject diaries. Participants will be followed for 6 months after study procedure.

Timeline

Start
2024-11-19
Primary completion
2027-02-01
Completion
2027-02-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Triamcinolone Other / unclassified 40 mg Other

Indications